FDA-Inspected Site

Rosemont Pharmaceuticals Ltd.

5 FDA inspections are on record for Rosemont Pharmaceuticals Ltd. in Leeds, United Kingdom.

Clean· No action indicated

Leeds, United Kingdom · Last updated August 15, 2026

Overview

  • 5 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2026-04-24.

At a glance

Inspections

5

Form 483s

1

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
20 Apr 2026 – 24 Apr 2026Human DrugsClean
6 Feb 2019 – 8 Feb 2019Human DrugsClean
8 Dec 2014 – 12 Dec 2014Human Drugs483View 483 →
13 Oct 2011Not recordedClean
10 May 2005Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

12 Dec 2014
21 CFR 211.166(a)

Results not used for expiration dates, storage cond.

Cited by Luis A Dasta

Investigators

FDA investigators tied to this site in the record.

MRA McCulloughJ1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Rosemont Pharmaceuticals Ltd.'s 1 Form 483

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat